FDA Inspection
CSL Plasma Inc.CSL Plasma Inc. – FDA Inspection, Feb 29, 2024
Record Details
This FDA Inspection record concerns CSL Plasma Inc., with an inspection on February 29, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 5caabe44-b922-49bb-8194-8e7fbea0f127
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1231372
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.20(b)Qualifications of responsible personnel
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CSL Plasma Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 21, 2019 | Not classified | New Jersey District Office |
Other documents for CSL Plasma Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.